Venture capital fundraising for Neurent Medical Ltd.

Neurant Medical

Pegasus Capital advised Neurent Medical Ltd. (“Neurent Medical”) on a EUR 9.3 million venture capital fundraising led by Fountain Healthcare Partners and Atlantic Bridge Capital.  Led by founders Brian Shields and David Townley, Neurent Medical is developing a device for the treatment of rhinitis, an inflammatory disease of the nose.  Rhinitis is the fifth most common chronic disease in the US and the most common chronic disease in children overall.  The funding round will support the early development of Neurent Medical’s device, and an expansion of its team in Galway.  The investment syndicate included a number of experienced Irish and international medical device investors.

YEAR: 2018
SECTOR: Lifesciences
TERMS: EUR 9,300,000